Company Encyclopedia
View More
name
Nutex Health
NUTX.US
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health.
186.36 B
NUTX.USMarket value -Rank by Market Cap -/-

Financial Score

14/12/2025 Update
A
Health Care FacilitiesIndustry
Industry Ranking1/23
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE63.86%A
    • Profit Margin12.29%B
    • Gross Margin59.70%A
  • Growth ScoreA
    • Revenue YoY236.03%A
    • Net Profit YoY393.10%A
    • Total Assets YoY119.96%A
    • Net Assets YoY449.06%A
  • Cash ScoreA
    • Cash Flow Margin813.81%B
    • OCF YoY236.03%A
  • Operating ScoreA
    • Turnover1.4A
  • Debt ScoreC
    • Gearing Ratio54.59%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Nutex Health (NUTX): Reassessing Valuation After New Legal Investigation and Short-Seller Allegations

    Nutex Health faces legal uncertainty as The Schall Law Firm investigates its billing practices following Blue Orca Capital's report. Despite a sharp stock recovery, concerns arise over its reliance on arbitration revenue and modest organic growth. Nutex is deemed 23.5% undervalued, with a fair value of $241.67, driven by successful value-based care and cost discipline. However, risks remain due to potential revenue challenges. Investors are advised to explore other healthcare stocks and assess growth levers for Nutex's future.

    Simplywall·
    US
    NUTX
    -2.94%
    Simplywall·
    US
    NUTX
    -2.94%

    Nutex Health (NASDAQ:NUTX) Hits New 1-Year High - Here's What Happened

    Nutex Health (NASDAQ:NUTX) shares reached a new 52-week high, trading as high as $187.20. Analysts have set new price targets, with Maxim Group rating it a 'buy' at $205.00. Institutional investors have adjusted their stakes, with Bank of America Corp DE increasing its holdings significantly. The company reported strong quarterly earnings, surpassing expectations with $7.76 EPS and $243.99 million revenue. Insider activity includes CFO Jon Christian Bates purchasing shares, increasing his position by 15.34%. Nutex Health operates in healthcare services, focusing on hospital, PHM, and real estate segments.

    Market Beat·
    US
    NUTX
    -2.94%
    Market Beat·
    US
    NUTX
    -2.94%

    AI adopters trade gaining steam; top stocks in AI adoption sectors

    Wall Street strategists are shifting focus from AI spenders to adopters, favoring companies benefiting from AI use. Michael Hartnett notes bond vigilantes are curbing AI capex growth. Rich Privorotsky highlights AI disruption and sees gains in corporate margins, favoring equal-weight S&P and emerging markets. Top AI adoption sectors include Financials, Industrials, Healthcare, and Retail, with stocks like Nutex Health, GRAIL, and Amazon among the top-rated by Quant Rating.

    businessinsider·
    US
    NUTX
    -2.94%
    businessinsider·
    US
    NUTX
    -2.94%

    Top 10 US Stock Gainers (12.8)

    Wave Life Sciences(WVE) rose 147.26%, with a trading turnover 2.4 Billion USD, and a year-to-date rose 49.7%. Structure Therapeutics(GPCR) rose 102.49%, with a trading turnover 1.3 Billion USD, and a year-to-date rose 158%. Fulcrum Therapeutics(FULC) rose 45.96%, with a trading turnover 343.3 Million USD, and a year-to-date rose 176.4%.

    Top Gainers & Losers·
    US
    WVE
    -1.13%
    US
    GPCR
    -0.56%
    US
    FULC
    +1.56%
    Top Gainers & Losers·
    US
    WVE
    -1.13%
    US
    GPCR
    -0.56%
    US
    FULC
    +1.56%

    Assessing Nutex Health’s Valuation After Buyback Extension and Red River ER & Hospital Reopening

    Nutex Health has extended its share buyback plan and reopened Red River ER & Hospital, boosting growth and capital returns. Despite a 351.58% YTD share price increase, Nutex is seen as undervalued with a fair value of $241.67. Improved margins and tech investments drive earnings growth, but risks include arbitration revenue reliance and governance concerns. Investors are encouraged to explore healthcare stocks and other investment opportunities. Simply Wall St provides analysis based on historical data and forecasts, not financial advice.

    Simplywall·
    US
    NUTX
    -2.94%
    Simplywall·
    US
    NUTX
    -2.94%
    © 2025 Longbridge｜Disclaimer